Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Endo to develop and commercialize Alexza's AZ-003 Staccato inhaled fentanyl

Jan. 2, 2008

Targeting ASICs may provide benefit in multiple sclerosis

Jan. 2, 2008

Antisense provides update on ATL-1102 phase IIa multiple sclerosis trial

Dec. 31, 2007

Collegium reports results for its abuse deterrent sustained release opioid study

Dec. 31, 2007

CytRx initiates phase IIb trial with arimoclomol for the treatment of ALS

Dec. 31, 2007

AVI BioPharma starts dosing in Duchenne muscular dystrophy trial

Dec. 31, 2007

Lundbeck and Paion expand license agreement for desmoteplase

Dec. 31, 2007

Pramipexole shows potential in treatment-resistant depression

Dec. 31, 2007

Noven reports FDA tentative approval of Stavzor valproic acid delayed release capsules

Dec. 28, 2007

ExonHit obtains approval to start phase II EHT-0202 trial in Alzheimer's disease

Dec. 28, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...